GlucoTrack (GCTK)
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of GlucoTrack (GCTK)
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Key Insights
Critical company metrics and information
Share Price
$0.14Market Cap
$2.23 MillionTotal Outstanding Shares
16.05 Million SharesTotal Employees
6Dividend
No dividendIPO Date
December 10, 2000SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQType
Common StockPhone Number
972 (8) 675-7878Address
301 rt 17 north, Rutherford, NJ, 07070Homepage
https://www.glucotrack.com
Historical Stock Splits
If you bought 1 share of GCTK before May 20, 2024, you'd have 0.20 shares today.
| Execution Date | Split Amount |
|---|---|
| May 20, 2024 | 1-for-5 (Reverse Split) |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $4.38 Million |
| Net Cash Flow From Investing Activities | $-238,000.00 |
| Net Cash Flow | $0.00 |
| Net Cash Flow From Investing Activities, Continuing | $-238,000.00 |
| Net Cash Flow From Financing Activities | $4.38 Million |
| Net Cash Flow From Operating Activities, Continuing | $-4.14 Million |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $-0.91 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Net Income/Loss Attributable To Parent | $-5.09 Million |
| Diluted Earnings Per Share | $-0.91 |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Income/Loss From Continuing Operations After Tax | $-5.09 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $826,000.00 |
| Fixed Assets | $109,000.00 |
| Noncurrent Assets | $184,000.00 |
| Other Current Liabilities | $2.75 Million |
| Noncurrent Liabilities | $237,000.00 |
| Equity Attributable To Noncontrolling Interest | $0.00 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2025 Financhle. All Rights Reserved.